Determination of interferon-alpha2 allele composition in the genomic DNA from healthy volunteers and leukemic patients in Japan.

The three interferon-alpha2 (IFN-alpha2) sequences identified to date differ from each other in just two nucleotide positions, both of which result in changes in amino acids. Thus, the mature IFN-alpha2a protein product is characterized by a lysine residue at position 23 (AAA) and a histidine at position 34 (CAA), IFN-alpha2b has an arginine at position 23 (AGA) and histidine at position 34 (CAT), and IFN-alpha2c has arginine residues at both positions 23 (AGA) and 34 (CGT). These nucleotide variations in the DNA sequence can be distinguished by selective restriction enzyme analysis. We studied the distributions of the three IFN-alpha2 variants by analyzing chromosomal DNA from 103 Japanese volunteers and 33 patients with hematologic disorders. Fragments of 238 bp and 617 bp of the IFN-alpha2 gene containing codons 23 and 34 were amplified by PCR using specific primers, and the PCR products were analyzed with specific restriction nucleases to identify the IFN-alpha2 variant sequences. Only IFN-alpha2b gene was detected in normal volunteers, and no IFN-alpha2a gene was detected in Japanese subjects. However, IFN-alpha2c was detected in 4 of 33 (12.1%) patients with leukemia.

[1]  M. Thursz,et al.  Detection of Rare Allelic Variants of the Interferon-α2 Gene in Human Genomic DNA , 1995 .

[2]  M. Liao,et al.  Interferon-alpha 2 variants in the human genome. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[3]  M. Liao,et al.  Interferon-α2 Produced by Normal Human Leukocytes Is Predominantly Interferon-α2b , 1994 .

[4]  M. Liao,et al.  Distribution of Interferon-α2 Genes in Humans , 1994 .

[5]  H. Heimpel,et al.  Roferon (rIFN-α2a) Is More Immunogenic Than Intron A (rIFN-α2b) in Patients with Chronic Myelogenous Leukemia , 1994 .

[6]  G. Antonelli,et al.  Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patients. , 1994, Journal of interferon research.

[7]  A. Lok,et al.  Interferon (IFN)-α2 Genotype Analysis of Chinese Chronic Hepatitis B Patients Undergoing Recombinant IFN-α2a Therapy , 1994 .

[8]  G. Antonelli,et al.  Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection. , 2008, Liver.

[9]  S. Pestka,et al.  Human interferon-alpha A, -alpha 2, and -alpha 2(Arg) genes in genomic DNA. , 1993, The Journal of biological chemistry.

[10]  D. Gewert,et al.  Analysis of Interferon-α2 Sequences in Human Genomic DNA , 1993 .

[11]  M. Imai,et al.  The interferon‐α2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon‐α2a , 1992, Journal of gastroenterology and hepatology.

[12]  L. Platanias,et al.  Correlation between interferon (IFN) alpha resistance and deletion of the IFN alpha/beta genes in acute leukemia cell lines suggests selection against the IFN system. , 1992, Blood.

[13]  K. Zoon,et al.  Purification and characterization of multiple components of human lymphoblastoid interferon-alpha. , 1992, The Journal of biological chemistry.

[14]  G. Jackson,et al.  Alpha interferon gene deletions in adults, children and infants with acute lymphoblastic leukemia. , 1991, Leukemia.

[15]  O. Turriziani,et al.  Neutralizing Antibodies to Interferon-α: Relative Frequency in Patients Treated with Different Interferon Preparations , 1991, The Journal of infectious diseases.

[16]  D. Grandér,et al.  Deletion of α-, β-, and ω-Interferon Genes in Malignant Cells from Children with Acute Lymphocytic Leukemia , 1990 .

[17]  J. Rowley,et al.  Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Longo,et al.  Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies. , 1988, The New England journal of medicine.

[19]  R. Spiegel,et al.  Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A). , 1986, The American journal of medicine.

[20]  J. Hoofnagle,et al.  Pilot study of recombinant human α-interferon for chronic type B hepatitis , 1986 .

[21]  C. Weissmann,et al.  The interferon genes. , 1986, Progress in nucleic acid research and molecular biology.

[22]  J. Brosius,et al.  Structural relationship of human interferon alpha genes and pseudogenes. , 1985, Journal of molecular biology.

[23]  T. Merigan,et al.  Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma. , 1984, The American journal of medicine.

[24]  D. Goeddel,et al.  DNA sequence of a major human leukocyte interferon gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.